JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2000; 35:600-604
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liem, A.
Right arrow Articles by Verheugt, F. W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liem, A.
Right arrow Articles by Verheugt, F. W. A.

High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial

Aylee Liem, MD*, Felix Zijlstra, MD*, Jan Paul Ottervanger, MD*, Jan C. A. Hoorntje, MD*, Harry Suryapranata, MD, FACC*, Menko-Jan de Boer, MD* and Freek W. A. Verheugt, MD, FACC{dagger}

* Hospital De Weezenlanden, Zwolle, the Netherlands
{dagger} University Hospital Nijmegen, Nijmegen, the Netherlands



View larger version (24K):

[in a new window]
  		Figure 1 Flow Chart. CABG = coronary artery bypass grafting.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2000 by the American College of Cardiology Foundation.